葛兰素史克Glaxosmithkline plc (GSK) 2000年年度报告「LSE」.pdf

1、GlaxoSmithKline01GlaxoSmithKline plcAnnual Report for the year ended 31st December 2000ContentsReport of the Directors02 Financial summary03 Joint statement by the Chairman and the Chief Executive Officer05 Description of business29 Corporate governance37 Remuneration report47 Operating and financia

2、l review and prospects69 Financial statements70 Directors statements of responsibility71 Report by the auditors72 Consolidated statement of profit and loss72 Consolidated statement of total recognised gains and losses74 Consolidated statement of cash flow76 Consolidated balance sheet76 Reconciliatio

3、n of movements in equity shareholders funds77 Company balance sheet78 Notes to the financial statements136 Group companies142 Principal financial statements in US$144 Financial record153 Investor information154 Shareholder return156 Taxation information for shareholders157 Shareholder information158

4、 Share capital160 Cross reference to Form 20-F162 Glossary of terms163 IndexContact detailsThe Annual Report was approved by the Boardof Directors on 22nd March 2001 and publishedon 12th April 2001.02GlaxoSmithKlineFinancial summary20001999IncreaseBusiness performancemmCER%Sales18,07916,164912Tradin

5、g profit5,0264,3781215Profit before taxation5,3274,7081113Earnings/Net income3,6973,2221315Earnings per Ordinary Share61.0p52.7p1416Total resultsProfit before taxation6,0294,236Earnings/Net income4,1542,859Earnings per Ordinary Share68.5p46.7pBusiness performance:results exclude merger items and res

6、tructuring costs;1999 sales and trading profit exclude the Healthcare Services businesseswhich were disposed of in 1999.CER%represents growth at constant exchange rates.%represents growth at actual exchange rates.Financial highlightsPharmaceutical sales up 10 per cent Sales growth in key therapeutic